A Multi-Omic Systems-Based Approach Reveals Metabolic Markers of Bacterial Vaginosis and Insight into the Disease Original paper
Researched by:
-
Divine Aleru
ID
Divine Aleru
I am a biochemist with a deep curiosity for the human microbiome and how it shapes human health, and I enjoy making microbiome science more accessible through research and writing. With 2 years experience in microbiome research, I have curated microbiome studies, analyzed microbial signatures, and now focus on interventions as a Microbiome Signatures and Interventions Research Coordinator.
-
Bacterial Vaginosis
Bacterial Vaginosis
Bacterial vaginosis (BV) is caused by an imbalance in the vaginal microbiota, where the typically dominant Lactobacillus species are significantly reduced, leading to an overgrowth of anaerobic and facultative bacteria.
-
Divine Aleru
Researched by:
-
Divine Aleru
ID
Divine Aleru
Microbiome Signatures identifies and validates condition-specific microbiome shifts and interventions to accelerate clinical translation. Our multidisciplinary team supports clinicians, researchers, and innovators in turning microbiome science into actionable medicine.
Divine Aleru
What was studied?
The study investigated the vaginal microbiome and metabolome of reproductive-age women to identify metabolic markers and microbial associations linked to bacterial vaginosis (BV). Researchers used a multi-omic systems-based approach, integrating deep 16S rRNA gene sequencing with metabolomic profiling of vaginal lavage samples collected from 36 women. This study sought to overcome the limitations of traditional diagnostic methods like the Nugent score and Amsel criteria, which have been criticized for inconsistency and inability to accurately capture symptomatic BV cases.
Who was studied?
The study involved 36 women of reproductive age, who varied demographically and behaviorally. Participants were clinically evaluated for BV using Amsel criteria and Nugent scoring. Vaginal lavage samples were collected from these women and subjected to both microbial and metabolic analyses. The cohort included both symptomatic and asymptomatic women, covering a diverse range of Nugent scores and BV symptoms, to enable the identification of associations between microbial taxa, metabolomic profiles, and disease status.
Most Important Findings
The study identified distinct microbial and metabolomic profiles associated with BV. It showed that microbial community composition, as assessed by 16S rRNA gene sequencing, reflected Nugent scores but poorly matched Amsel criteria. In contrast, metabolomic profiles were more aligned with Amsel-defined symptomatic BV, highlighting the potential diagnostic value of metabolic markers.
The researchers distinguished two symptomatic BV metabotypes (SBVI and SBVII), each linked to unique microbial and metabolic features. SBVI correlated with Mobiluncus spp. and Allisonella spp., while SBVII correlated with Hallella spp. Both metabotypes were marked by disruption of epithelial integrity but differed in microbial signatures and metabolic profiles.
Key microbial associations included increased abundance of Gardnerella spp. and Dialister spp. in samples with high Nugent scores. Dialister spp. correlated strongly with elevated levels of putrescine and cadaverine, compounds responsible for BV-associated odor. Mobiluncus spp. were associated with increased 2-methyl-2-hydroxybutanoic acid, linked to vaginal discharge, while Gardnerella spp. were connected to diethylene glycol, associated with vaginal pain. The study also noted that decreases in lactic acid-producing lactobacilli and increases in acetate- and propionate-producing bacteria characterized the BV state. Importantly, the relative abundance of Gardnerella spp. and Dialister spp. was not consistently associated with Amsel criteria, underscoring the complexity of the microbiome-symptom relationship.
Implications of this Study
This study advances understanding of BV by providing molecular-level evidence that the symptomatic state of BV cannot be attributed solely to microbial composition. Instead, it highlights that metabolic activity and metabolite production, driven by specific bacterial taxa, play a critical role in disease manifestation. The identification of two distinct symptomatic BV metabotypes suggests that BV is not a singular condition but may arise via different microbial and metabolic pathways. These findings imply that clinical diagnostics for BV should integrate metabolomic data alongside microbial profiling to improve accuracy and reduce misclassification based on Nugent score or Amsel criteria alone. These insights open avenues for targeted microbiome-based interventions and the development of metabolite-specific therapeutic strategies.
Metabolomic Signature
Metabolomic signatures are unique metabolite patterns linked to specific biological conditions, identified through metabolomics. They reveal underlying biochemical activities, aiding in disease diagnosis, biomarker development, and personalized medicine. The microbiome significantly affects these signatures, influencing health and disease outcomes through metabolic interactions.
Bacterial Vaginosis
Bacterial vaginosis (BV) is caused by an imbalance in the vaginal microbiota, where the typically dominant Lactobacillus species are significantly reduced, leading to an overgrowth of anaerobic and facultative bacteria.
Amsel Criteria
Amsel's Criteria is a clinically established diagnostic method for bacterial vaginosis, offering a practical and accessible alternative to laboratory-based approaches. It evaluates four key clinical indicators, ensuring timely diagnosis and intervention in outpatient settings.
Nugent Score
The Nugent Score is a standardized Gram stain-based scoring system used to diagnose bacterial vaginosis (BV) by assessing key bacterial morphotypes in vaginal samples. With its high specificity, it remains a gold standard in microbiome research, though its complexity and need for trained personnel make it less common in routine clinical practice.